Real-time enrollment status for this osteogenesis imperfecta (oi) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:36 PM UTC
| NCT Number | NCT07062588 |
| Recruiting Status | Recruiting |
| Condition | Osteogenesis Imperfecta (OI) |
| Phase | PHASE2 |
| Target Enrollment | 80 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Angitia Incorporated Limited |
| Last Updated on CT.gov | August 17, 2026 (Aug 17, 2026) |
As of October 12, 2026: Clinical trial NCT07062588 is currently recruiting participants. This phase2 study for osteogenesis imperfecta (oi) is actively seeking new participants at 9 locations across the United States. The study is sponsored by Angitia Incorporated Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07062588 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07062588 was last updated Aug 17, 2026 (August 17, 2026). HelloStudys verifies this status automatically.